Minimally invasive glaucoma surgery (MIGS) devices are becoming an important option for treating glaucoma patients due to their ab interno technique, which helps avoid both medication reliance and conjunctival invasion. These devices, including stents, shunts, and micro implants, are primarily used for patients with mild to moderate glaucoma.